The COVID-19 vaccine will be available as soon as December this year
A large US pharmaceutical company announced that the third phase of the clinical trial report of the COVID-19 vaccine showed that the effective prevention rate of the vaccine was as high as 90%, which was far higher than the 50% requirement of the US Food and Drug Administration (FDA). The pharmaceutical company pointed out that there were 43,538 participants in the test, 94 of whom were confirmed to be infected with the new coronavirus. However, the number of people still infected with the virus has not been announced. The market estimates that if the test process goes smoothly, the vaccine will be available as early as 12 this year. Available at the beginning of the month.
Z. com Bullion is an affiliate of GMO Financial Holdings, Inc., a Japanese listed group. The risk of loss in leveraged foreign exchange trading & margin trading can be substantial. Visit the company website to read full risk warning. https://bullion.z.com/en/about/legal/risk/